These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30566888)

  • 1. Make (No) Bones about Butyrate.
    Begka C; Marsland BJ
    Immunity; 2018 Dec; 49(6):994-996. PubMed ID: 30566888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression.
    Tyagi AM; Yu M; Darby TM; Vaccaro C; Li JY; Owens JA; Hsu E; Adams J; Weitzmann MN; Jones RM; Pacifici R
    Immunity; 2018 Dec; 49(6):1116-1131.e7. PubMed ID: 30446387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota.
    Li JY; Yu M; Pal S; Tyagi AM; Dar H; Adams J; Weitzmann MN; Jones RM; Pacifici R
    J Clin Invest; 2020 Apr; 130(4):1767-1781. PubMed ID: 31917685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sweet Memories of 8 Empowered by Butyrate.
    Ji L; Hu X
    Immunity; 2019 Aug; 51(2):201-203. PubMed ID: 31433964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate, a new microbiota-dependent player in CD8+ T cells immunity and cancer therapy?
    Danne C; Sokol H
    Cell Rep Med; 2021 Jul; 2(7):100328. PubMed ID: 34337557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota orchestrates PTH action in bone: role of butyrate and T cells.
    Massy ZA; Drueke TB
    Kidney Int; 2020 Aug; 98(2):269-272. PubMed ID: 32600825
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity.
    Boudousquié C; Danilo M; Pousse L; Jeevan-Raj B; Angelov GS; Chennupati V; Zehn D; Held W
    J Immunol; 2014 Sep; 193(6):2784-91. PubMed ID: 25127860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-Modulating Effect of Butyrate in the Prevention of Colon Cancer by Dietary Fiber.
    Chen J; Vitetta L
    Clin Colorectal Cancer; 2018 Sep; 17(3):e541-e544. PubMed ID: 29866614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate enhances antibacterial effects while suppressing other features of alternative activation in IL-4-induced macrophages.
    Fernando MR; Saxena A; Reyes JL; McKay DM
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G822-31. PubMed ID: 27012776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules.
    Shan YS; Fang JH; Lai MD; Yen MC; Lin PW; Hsu HP; Lin CY; Chen YL
    Mol Carcinog; 2011 Oct; 50(10):739-50. PubMed ID: 20737421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. n-Butyrate anergized effector CD4+ T cells independent of regulatory T cell generation or activity.
    Fontenelle B; Gilbert KM
    Scand J Immunol; 2012 Nov; 76(5):457-63. PubMed ID: 22724664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate.
    Lazarova DL; Bordonaro M; Carbone R; Sartorelli AC
    Int J Cancer; 2004 Jul; 110(4):523-31. PubMed ID: 15122584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt Signaling as Master Regulator of T-Lymphocyte Responses: Implications for Transplant Therapy.
    Staal FJ; Arens R
    Transplantation; 2016 Dec; 100(12):2584-2592. PubMed ID: 27861287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of bugs, bones and butyrate.
    Flemming A
    Nat Rev Immunol; 2019 Jan; 19(1):4-5. PubMed ID: 30546108
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death.
    Cheng LE; Ohlén C; Nelson BH; Greenberg PD
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3001-6. PubMed ID: 11867736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.
    Wang B; Tian T; Kalland KH; Ke X; Qu Y
    Trends Pharmacol Sci; 2018 Jul; 39(7):648-658. PubMed ID: 29678298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption.
    Shashkova EV; Trivedi J; Cline-Smith AB; Ferris C; Buchwald ZS; Gibbs J; Novack D; Aurora R
    J Immunol; 2016 Aug; 197(3):726-35. PubMed ID: 27324129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Formation and the Wnt Signaling Pathway.
    Rauner M; Rachner TD; Hofbauer LC
    N Engl J Med; 2016 Nov; 375(19):1902. PubMed ID: 27959644
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone Formation and the Wnt Signaling Pathway.
    Gori F; Superti-Furga A; Baron R
    N Engl J Med; 2016 Nov; 375(19):1902-1903. PubMed ID: 27959643
    [No Abstract]   [Full Text] [Related]  

  • 20. Is Wnt signalling the final common pathway leading to bone formation?
    Milat F; Ng KW
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):52-62. PubMed ID: 19524639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.